• 11/26/2024

Failure of ALS drug puts a spotlight on controversial FDA approvals

Washington Post

A large clinical trial found that Amylyx Pharmaceuticals’ drug to treat ALS doesn’t work, raising questions about the FDA’s process for approving it.

https://www.washingtonpost.com/business/2024/03/16/als-drug-relyvrio-fda/